Other languages AbbVie Inc.

Equities

ABBV

US00287Y1091

Market Closed - Nyse Other stock markets 04:00:02 2024-06-13 pm EDT			5-day change	1st Jan Change
166.6 ^USD	+0.28%		-1.19%	+7.48%

Jun. 13	AbbVie inks immune disorder drug licensing deal with China's FutureGen	RE
Jun. 13	AbbVie, FutureGen in License Pact for Inflammatory Bowel Disease Drug	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AbbVie inks immune disorder drug licensing deal with China's FutureGen	Jun. 13
AbbVie, FutureGen to Develop Potential Inflammatory Bowel Disease Treatment	Jun. 13
3 Top-Picks: Auf medizinische KI setzen	Jun. 13
Drie bedrijven om in te zetten op medische AI	Jun. 11
Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar	Jun. 11
Tre società su cui puntare nell’IA in campo medico	Jun. 11
Tres empresas para capitalizar la IA médica	Jun. 10
Trois sociétés pour miser sur l'IA médicale	Jun. 10
Le jour de la marmotte	Jun. 10
En Direct des Marchés : Stellantis, Crédit Agricole, LVMH, Volvo, Microsoft, Apple, Southwest Airlines...	Jun. 10
Borsa di Italia: Il giorno della marmotta	Jun. 10
Bolsa de Madrid: El día de la marmota	Jun. 10
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07
Calico Life Sciences LLC and AbbVie Announce That Fosigotifator (ABBV-CLS-7262) for Vanishing White Matter Disease Has Been Selected for the FDA Start Pilot Program	Jun. 07
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07
AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint	Jun. 06
AbbVie's ovarian cancer therapy succeeds in mid-stage trial	Jun. 06
AbbVie Inc. Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer	Jun. 06
AbbVie Says First Patient Treated in Phase 3 Trial Assessing Potential Blood Cancer Treatment	Jun. 05
EEUU - Valores a seguir en Wall Street (actualizado)	Jun. 05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AbbVie Inc.

Equities

ABBV

US00287Y1091

Other languages

Filters